Federal regulators say they’re still seeing a heavy dose of risk in large loans made by banks and other financial institutions, despite the recovering U.S. economy.
Wal-Mart expects its profit to take a hit as the world’s biggest retailer works to fend off intensifying competition by perking up customer service and adapting to changing shopping habits.
The Federal Reserve says steady consumer spending and an improving housing market spurred modest U.S. economic growth in the late summer, though factory output was sluggish in part because of the strong dollar.
A late turn gave the stock market a meager gain to start the month Thursday, a day after it finished its worst quarter in four years.
Just about everything broke right for the U.S. auto industry in September, as strong consumer demand, easy credit and generous incentives combined for double-digit sales gains at most major automakers.
U.S. stocks rose across the board Wednesday following big gains in Asia and Europe, a buoyant end to the worst quarter for the market in four years.
Inside Volkswagen’s only U.S. assembly plant there’s little hint of the diesel emissions cheating scandal embroiling the German automaker around the world.
Amtrak is boarding a baggage fee bandwagon that has generated billions in revenue for the airline industry.
Royal Dutch Shell has abandoned its long quest to become the first company to produce oil in Alaska’s Arctic waters, darkening the nation’s long-term oil prospects and delighting environmental groups that tried to block the project.
Chinese companies have agreed with Boeing to buy 300 jets and build an aircraft assembly plant in China in deals signed during President Xi Jinping’s visit to the United States, the official Xinhua news agency said Wednesday.
Another slide in raw-material producers and oil companies tugged the stock market to a slight loss on Wednesday, amid heightened concerns about global economic growth. Dow Chemical and Chevron each lost 2 percent.
Single pill cost jumped from $13.50 to $750
The company that sparked an angry backlash after it raised the price of a drug for treating a deadly parasitic infection by more than 5,000 percent says it will roll back some of the increase.
Leaders of two major health insurers planning multibillion dollar acquisitions made their case to Congress that bigger can mean better in their industry, but concerns are being raised in Washington about how these deals will affect consumers and competition.
Employers are leaving a bigger chunk of the bill for care to workers who use their health insurance, and benefits experts see few signs of this trend slowing.
Fears over slowing global growth hammered stocks in the U.S. and Europe on Friday and lifted prices of government bonds and other assets seen as safer bets.